The senior director and clinical program leader, Translational Clinical Oncology at Novartis Institutes for BioMedical Research, discussed new data from the phase 1 study.
Serena De Vita, MD, PhD
Advertisement
Articles by Serena De Vita, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
2
Autologous Stem Cell Therapy for Alzheimer Disease Advances to Phase 2 After Positive Early Findings
3
Around the Helix: Cell and Gene Therapy Company Updates – December 3, 2025
4
Lessons Learned From the Past 25 Years of Cell and Gene Therapy Research
5
